Severe sepsis carries significant morbidity, mortality and high costs. This book reviews novel targets to be considered in patients with severe sepsis. It assess new developments for patients with sepsis originating in the respiratory tract.
Sepsis is an important public health problem around the world. Severe sepsis carries significant morbidity, mortality and high costs. The incidence of sepsis is increasing because of the aging population, the growing number of immunocompromised hosts, the increasing use of invasive procedures, and, to a lesser extent, antibiotic resistance among pathogens. Despite recent advances in the pathogenesis, diagnosis, and therapeutic approaches the mortality rate associated with this condition remains high. Therefore, the goal of Sepsis: New Strategies is to review novel targets to be considered in patients with severe sepsis and to assess new developments for patients with sepsis originating in the respiratory tract.
Macrolides in Severe Community-Acquired Pneumonia and Sepsis.- The Potential Role of Statins in Severe Sepsis.- The Genetics of Sepsis: The Promise, the Progress and the Pitfalls.- Corticoids in Severe Pneumonia.- Aging, Inflammation, and Pneumococcal Disease.- Nonspecific Removal of Sepsis Mediators.- Optimal Antibiotic Use in Severe Community-Acquired Pneumonia.- Dose Adjustment and Pharmacodynamic Considerations for Antibiotics in Severe Sepsis and Septic Shock.
From the reviews:
"This brief monograph reviews immunomodulatory and anti-inflammatory strategies under investigation as adjuncts in management of sepsis and pneumonia. ... Practitioners with an academic interest in sepsis are an appropriate audience for this work ... . Chapters are clearly written and tables and line drawings have good pedagogic quality." (David J. Dries, Doody's Review Services, January, 2009)
